These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11699725)

  • 1. Inverse correlation between macrophage-colony stimulating factor, cholesterol and high density lipoprotein cholesterol in Kawasaki disease.
    Shikishima Y; Kawano Y; Shirai H; Matsuura N; Noma T
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):85-91. PubMed ID: 11699725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High serum levels of M-CSF and G-CSF in Kawasaki disease.
    Igarashi H; Hatake K; Tomizuka H; Yamada M; Gunji Y; Momoi MY
    Br J Haematol; 1999 Jun; 105(3):613-5. PubMed ID: 10354120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of macrophage colony-stimulating factor in patients with Kawasaki disease complicated by cardiac lesions.
    Igarashi H; Hatake K; Shiraishi H; Samada K; Tomizuka H; Momoi MY
    Clin Exp Rheumatol; 2001; 19(6):751-6. PubMed ID: 11791654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased macrophages, high serum M-CSF and low serum cholesterol in myelodysplasia and Kawasaki disease.
    Shetty V; Allampallam K; Raza A
    Br J Haematol; 1999 Sep; 106(4):1068. PubMed ID: 10520017
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.
    Connelly MA; Shimizu C; Winegar DA; Shalaurova I; Pourfarzib R; Otvos JD; Kanegaye JT; Tremoulet AH; Burns JC
    BMC Pediatr; 2016 Sep; 16(1):151. PubMed ID: 27596163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum granulocyte colony-stimulating factor correlates with coronary artery dilatation in Kawasaki disease.
    Samada K; Igarashi H; Shiraishi H; Hatake K; Momoi MY
    Eur J Pediatr; 2002 Oct; 161(10):538-41. PubMed ID: 12297900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant relationship between serum high-sensitivity C-reactive protein, high-density lipoprotein cholesterol levels and children with Kawasaki disease and coronary artery lesions.
    Ou CY; Tseng YF; Lee CL; Chiou YH; Hsieh KS
    J Formos Med Assoc; 2009 Sep; 108(9):719-24. PubMed ID: 19773210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cholesterol levels during and after Kawasaki disease.
    Salo E; Pesonen E; Viikari J
    J Pediatr; 1991 Oct; 119(4):557-61. PubMed ID: 1919886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipids in north Indian children treated for kawasaki disease.
    Mitra A; Singh S; Devidayal ; Khullar M
    Int Heart J; 2005 Sep; 46(5):811-7. PubMed ID: 16272772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines in Kawasaki disease: measurement of CCL2, CCL22 and CXCL10.
    Shikishima Y; Saeki T; Matsuura N
    Asian Pac J Allergy Immunol; 2003 Sep; 21(3):139-43. PubMed ID: 15032397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease.
    Lee KY; Han JW; Lee JS; Whang KT
    Acta Paediatr; 2002; 91(2):164-7. PubMed ID: 11952003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum M-CSF levels in Kawasaki disease.
    Oana S; Terai M; Kohno Y
    Br J Haematol; 1999 Nov; 107(2):462-3. PubMed ID: 10583242
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease.
    Conran N; Saad ST; Costa FF; Ikuta T
    Ann Hematol; 2007 Apr; 86(4):255-61. PubMed ID: 17205286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease.
    Cabana VG; Gidding SS; Getz GS; Chapman J; Shulman ST
    Pediatr Res; 1997 Nov; 42(5):651-5. PubMed ID: 9357939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of peripheral blood toxic neutrophils as a predictor of coronary risk in Kawasaki disease--the pathogenetic role of hematopoietic colony-stimulating factors (GM-CSF, G-CSF).
    Takeshita S; Sekine I; Fujisawa T; Yoshioka S
    Acta Paediatr Jpn; 1990 Oct; 32(5):508-14. PubMed ID: 1704677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
    Abe J; Ebata R; Jibiki T; Yasukawa K; Saito H; Terai M
    J Allergy Clin Immunol; 2008 Nov; 122(5):1008-1013.e8. PubMed ID: 18930517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered lipid profile after Kawasaki syndrome.
    Newburger JW; Burns JC; Beiser AS; Loscalzo J
    Circulation; 1991 Aug; 84(2):625-31. PubMed ID: 1860206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of TLR2, 3, 9 and Signaling Mediators, MyD88 and TRIF, Gene Transcript Levels in Patients with Kawasaki Disease Treated with IVIG.
    Mortazavi SH; Amin R; Alyasin S; Kashef S; Karimi MH; Babaei M; Younesi V
    Iran J Allergy Asthma Immunol; 2015 Apr; 14(2):188-97. PubMed ID: 25780885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant human macrophage colony-stimulating factor on plasma cholesterol levels.
    Stoudemire JB; Garnick MB
    Blood; 1991 Feb; 77(4):750-5. PubMed ID: 1993217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.